Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PRECIGEN, INC. (XON)
|
Add to portfolio |
|
|
|
| Price: |
$3.98
| | Metrics |
| OS: |
255.5
|
M
| |
13
|
% ROE
|
| Market cap: |
$1.02
|
B
| |
|
|
|
Net cash:
|
$95.6
|
M
| |
$0.37
|
per share
|
|
EV:
|
$921
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$11.3
|
M
| |
81.8
|
x EV/EBITDA
|
|
EBIT
|
|
| |
|
|
| EPS |
$0.14
| |
27.7
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 26.9 | 14.3 | 32.0 | 90.7 | 151.2 | 219.5 | 190.9 | 173.6 |
| Revenue growth | 88.6% | -55.4% | -64.7% | -40.0% | -31.1% | 14.9% | 10.0% | 141.4% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 63.9 |
| Gross profit | 26.9 | 14.3 | 32.0 | 90.7 | 151.2 | 219.5 | 190.9 | 109.7 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 63.2% |
| Selling, general and administrative | 0.5 | 0.0 | 9.6 | 87.9 | 0.0 | 16.8 | 142.3 | 109.1 |
| Research and development | | | | | | | 112.1 | 147.5 |
| EBITA | 32.6 | 19.5 | 36.1 | 89.3 | 151.2 | 216.7 | -131.1 | -145.9 |
| EBITA margin | 121.0% | 136.9% | 112.7% | 98.4% | 100.0% | 98.7% | -68.7% | -84.1% |
| Amortization of intangibles | 4.8 | 5.3 | 5.2 | 7.9 | 11.7 | 11.5 | 15.2 | 9.9 |
| EBIT | 27.8 | 14.3 | 30.8 | 81.3 | 139.6 | 205.2 | -146.3 | -155.8 |
| EBIT margin | 103.2% | 100.0% | 96.3% | 89.7% | 92.3% | 93.5% | -76.6% | -89.7% |
| Pre-tax income | -80.0 | -111.0 | -104.5 | -171.3 | -395.9 | -78.4 | -194.2 | -87.0 |
| Income taxes | -0.2 | 0.2 | 0.1 | -0.9 | -15.4 | 2.1 | -3.9 | 1.0 |
| Tax rate | 0.2% | | | 0.5% | 3.9% | | 2.0% | |
| Earnings from continuing ops | -79.8 | -92.2 | -170.5 | -168.7 | -375.1 | -117.0 | -186.6 | -84.5 |
| Earnings from discontinued ops | 108.1 | 18.6 | -66.1 | -153.6 | -134.2 | | | |
| Net income | 28.3 | -92.2 | -170.5 | -322.3 | -509.3 | -117.0 | -186.6 | -84.5 |
| Net margin | 105.2% | -646.0% | -533.0% | -355.3% | -336.9% | -53.3% | -97.7% | -48.7% |
| |
| Diluted EPS | ($0.40) | ($0.47) | ($1.02) | ($1.09) | ($2.90) | ($0.98) | ($1.58) | ($0.76) |
| Shares outstanding (diluted) | 200.4 | 197.8 | 167.1 | 154.1 | 129.5 | 120.0 | 118.0 | 111.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|